Intravascular Ultrasound in the Endovascular Treatment of Patients With Peripheral Arterial Disease: Current Role and Future Perspectives.

atherectomy intravascular ultrasound (IVUS) percutaneous transluminal angioplasty (PTA) peripheral arterial disease stent placement

Journal

Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388

Informations de publication

Date de publication:
2020
Historique:
received: 14 04 2020
accepted: 16 11 2020
entrez: 21 12 2020
pubmed: 22 12 2020
medline: 22 12 2020
Statut: epublish

Résumé

Over the last decade, intravascular ultrasound (IVUS) has emerged as a useful adjunctive tool to angiography in an increasing number of catheter-based procedures for peripheral arterial disease (PAD). IVUS catheters offer accurate cross-sectional imaging of arterial vessels with high dimensional accuracy and provide accurate information about lesion morphology. IVUS enables assessment of the plaque morphology, vessel diameter, and the presence of arterial dissections. Furthermore, IVUS is able to properly guide the best choice of appropriate percutaneous transluminal angioplasty (PTA) technique, guide the delivery of different devices, and assess the immediate result of any endovascular intervention. In the present review, the role of IVUS for PAD will be discussed, specifically the applications of IVUS technology during interventional procedures including PTA, stent sizing, crossing total occlusion, assessing residual narrowing and stent apposition and expansion, and atherectomy. Future perspectives of IVUS-guided treatments and cost-effectiveness of the systematic use of IVUS during endovascular interventions will be also discussed.

Identifiants

pubmed: 33344512
doi: 10.3389/fcvm.2020.551861
pmc: PMC7738328
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

551861

Informations de copyright

Copyright © 2020 Loffroy, Falvo, Galland, Fréchier, Ledan, Midulla and Chevallier.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Methodist Debakey Cardiovasc J. 2012 Oct-Dec;8(4):28-32
pubmed: 23342185
Cardiovasc Revasc Med. 2012 Jul-Aug;13(4):219-23
pubmed: 22632996
J Endovasc Ther. 2017 Aug;24(4):478-487
pubmed: 28504047
Ther Adv Cardiovasc Dis. 2018 Jan;12(1):17-22
pubmed: 29265002
Semin Vasc Surg. 2006 Sep;19(3):155-62
pubmed: 16996418
J Endovasc Ther. 2019 Jun;26(3):322-330
pubmed: 30873909
J Vasc Surg. 2002 Feb;35(2):316-23
pubmed: 11854730
Tech Vasc Interv Radiol. 2004 Mar;7(1):23-7
pubmed: 15071777
J Endovasc Ther. 2020 Feb;27(1):77-85
pubmed: 31948376
J Endovasc Ther. 2014 Aug;21(4):485-92
pubmed: 25101575
Int J Cardiovasc Imaging. 2018 Mar;34(3):345-352
pubmed: 28952037
Circulation. 2001 Jan 30;103(4):604-16
pubmed: 11157729
J Vasc Surg. 2006 Jun;43(6):1291-6
pubmed: 16765258
J Endovasc Ther. 2004 Jun;11(3):274-80
pubmed: 15174902
Eur Heart J. 2016 Oct 21;37(40):3090-3095
pubmed: 26957421
Int J Cardiovasc Intervent. 2000 Dec;3(4):207-213
pubmed: 12431345
Vasc Health Risk Manag. 2019 Aug 07;15:283-290
pubmed: 31496717
J Invasive Cardiol. 2018 Jul;30(7):240-244
pubmed: 29958175
JACC Cardiovasc Interv. 2015 Dec 21;8(14):1893-901
pubmed: 26604061
J Endovasc Ther. 2008 Feb;15(1):117-25
pubmed: 18254670
JACC Cardiovasc Interv. 2014 Nov;7(11):1287-93
pubmed: 25326742
Ann Vasc Surg. 2015 Jan;29(1):55-62
pubmed: 25449989
Int Angiol. 2017 Dec;36(6):505-516
pubmed: 28895369
Expert Rev Med Devices. 2013 Nov;10(6):735-49
pubmed: 24195458
J Invasive Cardiol. 2020 Mar;32(3):99-103
pubmed: 32123141
Cardiovasc Interv Ther. 2014 Jan;29(1):40-6
pubmed: 24068528
J Vasc Surg. 2010 Apr;51(4):933-8; discussion 939
pubmed: 20080002
Ann Vasc Surg. 2010 May;24(4):487-97
pubmed: 20363107
Circ J. 2011;75(1):179-84
pubmed: 21099122
J Endovasc Ther. 2016 Feb;23(1):65-75
pubmed: 26637836
Catheter Cardiovasc Interv. 2008 May 1;71(6):727-33
pubmed: 18412065
J Invasive Cardiol. 2019 May;31(5):121-126
pubmed: 31034434
Semin Vasc Surg. 2006 Sep;19(3):139-44
pubmed: 16996415

Auteurs

Romaric Loffroy (R)

Department of Vascular Medicine and Interventional Radiology, François-Mitterrand University Hospital, Dijon, France.

Nicolas Falvo (N)

Department of Vascular Medicine and Interventional Radiology, François-Mitterrand University Hospital, Dijon, France.

Christophe Galland (C)

Department of Vascular Medicine and Interventional Radiology, François-Mitterrand University Hospital, Dijon, France.

Léo Fréchier (L)

Department of Vascular Medicine and Interventional Radiology, François-Mitterrand University Hospital, Dijon, France.

Frédérik Ledan (F)

Department of Vascular Medicine and Interventional Radiology, François-Mitterrand University Hospital, Dijon, France.

Marco Midulla (M)

Department of Vascular Medicine and Interventional Radiology, François-Mitterrand University Hospital, Dijon, France.

Olivier Chevallier (O)

Department of Vascular Medicine and Interventional Radiology, François-Mitterrand University Hospital, Dijon, France.

Classifications MeSH